Successful treatment of breakthrough trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia

Abstract

We describe a 55-year-old man with acute myelogenous leukemia who developed breakthrough Trichosporon asahii fungemia during 5 days of micafungin treatment. Although the patients clinical condition improved considerably after the start of voriconazole treatment, blood culture Results remained positive for T. asahii for 3 days, and fever persisted for 7 days thereafter. The patient achieved complete hematological remission, and he received successful consolidation chemotherapy without developing Trichosporon infection with the prophylactic use of voriconazole therapy. This case report illustrates that voriconazole may be useful in the treatment of disseminated T. asahii infection in neutropenic patients. © 2006 by the Infectious Diseases Society of America. All rights reserved.